Anifertil, containing the progestin Chlormadinone Acetate (CMA), is applied to support hormonal control for veterinary reproductive management in cattle, the medicine's target species. It is relevant for managing conditions and symptomatic patterns that may create noticeable physiological strain.

Therapeutic Focus and Benefits

This medicine is commonly used across domains where additional symptomatic support is needed to address conditions that manifest with absent or highly irregular heat signs (anoestrus), uncoordinated reproductive cyclicity across a group, and abnormal estrus behaviors linked to specific ovarian pathologies like follicular cysts.

It is relevant in situations requiring temporary assistance in symptom stabilization, and may assist with maintaining functional stability in the herd during periods of heightened symptoms. The overall goal is to support efforts for managing symptoms related to systemic imbalance and contributing to the patient's reproductive stability.

Quick Fact: Relief for Reproductive Dysfunctions

Anifertil is primarily used for managing symptoms related to estrus synchronization and applied in addressing clinical conditions such as anoestrus and nymphomania associated with cystic ovaries.

Eligibility Scope for Anifertil (Chlormadinone Acetate)

Anifertil is a prescription-only veterinary medicine, meaning use is restricted to cattle (cows and heifers) and requires administration by or on the order of a licensed veterinarian. Its official eligibility profile is strictly defined by regulatory documents based on the animal's health and physiological status.

Eligibility Classification	Official Regulatory Rule
Contraindicated (Must NOT use)	Confirmed pregnancy, known hypersensitivity to Chlormadinone Acetate (CMA), severe uterine pathology (e.g., pyometra), or non-target animal species.
Conditional Use Only	Animals must be reproductively mature (not prepubertal) and in good general health, as use is restricted in animals with severe hepatic impairment or poor systemic condition.
Lactation Status	Use is permitted in lactating cattle, but the product is subject to mandatory milk and meat withdrawal periods. Edible products from treated animals must not enter the human food chain until these periods have elapsed, as defined in the official label.

Interactions with other medicines and products

The official interaction profile for Anifertil, containing the progestin Chlormadinone Acetate (CMA), is defined by pharmacokinetic interactions that can alter the concentration of the active ingredient.

Medicinal products classified as Hepatic Enzyme Inducers are documented in regulatory sources to accelerate the metabolic breakdown and clearance of CMA in the liver. This mechanism leads to a reduction in the systemic plasma concentration of CMA, resulting in decreased overall exposure (lowered AUC and Cmax). This exposure modification is classified as a clinically significant interaction due to the potential risk of reduced pharmacological efficacy.

Examples of agents cited in regulatory documentation that cause this pharmacokinetic effect include the antibiotic Rifampicin and the antifungal agent Griseofulvin. These are key instances of the drug class that can alter CMA exposure by inducing hepatic enzymes.

Official regulatory labeling does not specify any medicinal products as formally contraindicated (prohibited co-administration) solely based on interaction risk. There are also no documented mandatory requirements for separating the administration of Anifertil by a specific number of hours from other interacting substances.

How Anifertil Works

The mechanism of Anifertil is defined by its selective, dual-action approach, targeting key physiological pathways found in the target organism's biology.

️ Disrupting Nerve and Muscle Control

Anifertil acts as an agonist on specific ligand-gated ion channels found exclusively in the target organism's nerve and muscle cells. This interaction causes an immediate and sustained hyperpolarization of the cells, which halts all nervous transmission and leads to flaccid paralysis. The resulting paralysis disrupts the motor function and physical attachment capacity of the organism.

---

️ Blocking Energy Production

The drug acts as an inhibitor on specific enzymes within the organism's anaerobic energy metabolism pathway, such as fumarate reductase. This targeted interference blocks the synthesis of ATP, the core energy molecule. This second mechanistic domain facilitates a state of acute energy depletion and metabolic failure, resulting in the collapse of vital physiological systems.

How to Use Anifertil

Administration of Anifertil is governed by specific protocols for veterinary reproductive management. The principles of its usage focus strictly on standardized dosing and a time-limited schedule.

---

Official Administration Guidelines

The medicine is designed for oral administration as a tablet. Usage protocols require a fixed-dose regimen to be followed, meaning a standardized quantity, such as one tablet, is given per animal per day, rather than being adjusted according to individual body weight. This approach is typical for reproductive synchronization efforts in cattle, the medicine's target species.

Instruction	Detail
Route of administration	Oral
Dosing schedule	Fixed-dose per animal (e.g., one tablet)
Frequency pattern	Once daily

---

Procedural Course Structure

The full daily dose must be consumed by the animal to ensure proper delivery of the active ingredient, Chlormadinone Acetate (CMA). Administration is strictly restricted to an intermittent, time-limited course, and is not intended for continuous use. The typical course length mandated for achieving the desired hormonal control, such as estrus synchronization or treatment of anoestrus, is 14 consecutive days. Following the final dose, adherence to specified withdrawal periods is required before the animal can enter the food supply.

The overall use protocol requires precise adherence to this fixed, daily oral administration over the short, defined duration to structure the reproductive cycle.

Research Evidence / Overview of Studies for Anifertil

The following information summarizes the scientific research that has explored the use of Anifertil (Chlormadinone Acetate or CMA) in its target species, cattle, based on regulatory and peer-reviewed scientific sources. The research describes group patterns observed in studies but does not determine whether an individual animal will respond similarly.

---

Evidence for Managing Anoestrus and Follicular Cysts

Research has explored the use of this medicine in settings involving cattle diagnosed with specific reproductive difficulties, such as the persistent absence of heat (anoestrus) or abnormal cycling behaviors (nymphomania) linked to ovarian follicular cysts. Studies in this area primarily consisted of small-scale controlled trials and observational studies.

Research has examined outcomes related to systemic or functional imbalance, with the focus being the change in the size of ovarian cysts and whether the animals later resumed normal reproductive cycles. Trials also monitored the subsequent pregnancy rates in the animals observed. Evidence remains limited and heterogeneous, and the results apply only to the populations studied.

---

Evidence for Estrus Synchronization Protocols

This evidence base, primarily from Randomized Controlled Trials (RCTs) and systematic reviews, was studied for its use in estrus synchronization—coordinating the reproductive cycles across a herd. These studies examined outcomes related to daily functioning or activity level, specifically the rate of synchronized estrus response, a measure of the timing of breeding.

Trials reported how symptoms evolved in the observed populations, with data showing patterns related to conception rates and pregnancy rates following the protocol. However, these reported outcomes usually reflect the outcomes of the complete multi-hormone protocol, not solely the CMA component.

---

Evidence Gaps and Areas of Scientific Uncertainty

Long-term effects are not fully established beyond the first breeding cycle following the intervention. Furthermore, comparative evidence is limited when evaluating the oral CMA formulation against other alternative progestin delivery systems used today, and the available data often reflect specific, older research protocols.

Common questions about Anifertil (FAQ)

---

Q: Is Anifertil safe to use in calves or bulls?

According to the official product information, Anifertil is specifically indicated for use in heifers and cows as part of reproductive management protocols. Use of the medicine is contraindicated, or prohibited, in non-target animal species. This means the medicine is not intended for bulls or calves, as the product is indicated only for heifers and cows.

---

Q: Where can I purchase Anifertil?

Official regulatory documents classify Anifertil as a prescription-only veterinary medicine. Due to its status, Anifertil is typically purchased and used under the direction of a licensed veterinarian.

---

Q: Are there any food or dietary restrictions when using Anifertil?

The official regulatory labeling details potential interactions with other medicines, such as those classified as Hepatic Enzyme Inducers. While drug-drug interactions are documented, the labeling does not specify any food or dietary restrictions that require separate administration when using Anifertil.

The storage and disposal of Anifertil (Chlormadinone Acetate tablets) must strictly follow the official instructions provided in the regulatory datasheet, which define the product's required environmental and handling conditions.

Official Storage and Disposal Requirements

• Storage Environment: The specific temperature range for Anifertil is detailed in its official labeling. The medicine must be stored securely and protected from factors that cause deterioration, such as extremes of temperature, light, and high moisture, to maintain the tablet’s stability.
• Child Safety: In accordance with regulatory requirements for potent medicinal products, Anifertil must be kept strictly out of the sight and reach of children.
• Disposal: Unused or expired Anifertil must not be discarded through household waste or wastewater. All waste medicinal product must be disposed of according to local requirements to prevent the synthetic hormonal substance from entering the environment.